Tonix Pharmaceuticals Receives Positive FDA Feedback on Tonmya for Fibromyalgia Management
Tonix Pharmaceuticals announces positive FDA feedback on Tonmya sublingual tablets for fibromyalgia management, marking a crucial step forward in the regulatory process.
This news matters as it signifies a crucial step forward in the regulatory process for Tonmya sublingual tablets, potentially providing a new, effective treatment option for fibromyalgia patients.
